Author： Liu Guoyan Yang Da Sun Yan Shmulevich Ilya Xue Fengxia Sood Anil K Zhang Wei
Publisher： Future Medicine
ISSN： 1462-2416
Source： Pharmacogenomics, Vol.13, Iss.13, 2012-10, pp. : 1523-1535
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico
By Villarreal-Garza Cynthia Alvarez-Gómez Rosa María Pérez-Plasencia Carlos Herrera Luis A. Herzog Josef Castillo Danielle Mohar Alejandro Castro Clementina Gallardo Lenny N. Gallardo Dolores Santibáñez Miguel Blazer Kathleen R. Weitzel Jeffrey N.
Cancer, Vol. 121, Iss. 3, 2015-02 ,pp. :
Access to resources
Recommend
By Sakamoto Ikuko Hirotsu Yosuke Nakagomi Hiroshi Ouchi Hidetaka Ikegami Atsushi Teramoto Katsuhiro Amemiya Kenji Mochizuki Hitoshi Omata Masao
Cancer, Vol. 122, Iss. 1, 2016-01 ,pp. :
By Lucas Aimee L. Frado Laura E. Hwang Caroline Kumar Sheila Khanna Lauren G. Levinson Elana J. Chabot John A. Chung Wendy K. Frucht Harold
Cancer, Vol. 120, Iss. 13, 2014-07 ,pp. :
Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2
By Jackson Sarah A. Davis Andrew A. Li Jun Yi Nengjun McCormick Shelley R. Grant Carly Fallen Taya Crawford Beth Loranger Kate Litton Jennifer Arun Banu Vande Wydeven Kimberly Sidani Amer Farmer Katie Sanders Merideth Hoskins Kent Nussbaum Robert Esserman Laura Garber Judy E. Kaklamani Virginia G.
Cancer, Vol. 120, Iss. 10, 2014-05 ,pp. :